Judge shuts down Boehringer challenge to Merck Sharp & Dohme parasite patent
Agriculture 2020-09-24 1:59 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Pharmaceutical company Boehringer Ingelheim has failed in its Federal Court challenge to a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au